Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836264PMC
http://dx.doi.org/10.1097/JCP.0b013e3182793843DOI Listing

Publication Analysis

Top Keywords

effects cannabinoid-1
4
cannabinoid-1 receptor
4
receptor antagonist/inverse
4
antagonist/inverse agonist
4
agonist rimonabant
4
rimonabant satiety
4
satiety signaling
4
signaling overweight
4
overweight people
4
people schizophrenia
4

Similar Publications

G-protein-coupled receptors (GPCRs) constitute one of the most prominent families of integral membrane receptor proteins that mediate most transmembrane signaling processes. Malfunction of these signal transduction processes is one of the underlying causes of many human pathologies (Parkinson's, Huntington's, heart diseases, etc), provoking that GPCRs are the largest family of druggable proteins. However, these receptors have been targeted traditionally by orthosteric ligands, which usually causes side effects due to the simultaneous targeting of homologous receptor subtypes.

View Article and Find Full Text PDF

A Review of Cardiovascular Effects of Marijuana Use.

J Cardiopulm Rehabil Prev

November 2024

Author Affiliations: Marshfield Clinic Research Institute, Marshfield, Wisconsin (Dr Rezkalla); Cardiovascular Research Institute, Huntington Medical Research Institutes, Pasadena, California (Dr Kloner); and Cardiovascular Division, Dept. of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California (Dr Kloner).

Objective: Cannabinoids exert their effects on body tissues via cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. Receptors are present in brain, myocardium, vascular endothelium, platelets, and adipose tissues. Under normal physiologic conditions, endocannabinoid effects are minimal.

View Article and Find Full Text PDF

A combination of peripherally restricted CB and CB cannabinoid receptor agonists reduces bladder afferent sensitisation in cystitis.

Eur J Pharmacol

December 2024

Discipline of Human Physiology, Flinders Health & Medical Research Institute, College of Medicine and Public Health, Flinders University, South Australia, Australia. Electronic address:

Cannabinoid agonists can potentially ameliorate lower urinary tract symptoms (LUTS), including pain associated with interstitial cystitis/bladder pain syndrome (IC/BPS). This study aims to determine the contributions of the cannabinoid 1 receptors (CBRs) and CBRs in regulating the activity of different functional classes of afferents, comparing normal healthy bladder with bladders from guinea pigs with protamine/zymosan-induced cystitis. The mechanosensitivity of different functional afferent classes was determined by ex vivo single-unit extracellular recordings.

View Article and Find Full Text PDF

Visual exposure to dim, green, light has been found to reduce pain levels in patients living with migraine, low back pain, and fibromyalgia. Preclinical studies discovered that the analgesic effect of green light was due to the central release of endogenous opioids and a reduction in inflammatory cytokines in the cerebrospinal fluid. The present study assessed the effect of green light therapy (GLT) on joint pain in a rat model of osteoarthritis (OA) and investigated the role of endolipids.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the main active component of cannabis, THC, affects the signaling of extracellular vesicles (EVs) in the brain, which play a role in intercellular communication.
  • THC was found to activate certain cells in the brain, leading to increased expression of cannabinoid receptors and the release of EVs containing RNA.
  • Additionally, the research showed that both acute and chronic THC exposure had different effects on EV proteins, with variations based on sex, enhancing our understanding of cannabis's impact on brain signaling.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!